53 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... Aspergillosis #Treatment #pharmacology ... #dosing #medications ... #IDSA #Guidelines
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Tuberculosis - IDSA ... Guidelines # ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Antirheumatic Medication ... #rheumatology #medications ... perioperative #guidelines ... management #autoimmune #pharmacology
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... COVID-19 Specific Medications ... #criticalcare #Guidelines
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... #Roflumilast #Indications ... #Pharmacology #
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Bacteriuria - IDSA ... Indications for ... www.idsociety.org/practice-guideline ... #Bacteriuria #IDSA ... #Indications #Treatment
Management of type 2 diabetes in adults: summary of updated NICE guidance
#diabetes #type2 #DM2 #management #NICE
management #NICE #guidelines ... #medications #insulin
Intranasal Medication Delivery in the ED
#Pharmacology #EM #PSA #Intranasal #Pain #Medications #ComparisonTable
Intranasal Medication ... Delivery in the ED #Pharmacology ... #EM #PSA #Intranasal ... #Pain #Medications
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... clinical practice guideline1 ... 5.2 and 5.4 #EBM ... #Management #Pharmacology ... Personality #Disorder #Medications
Indications and absolute vs relative contraindications and outcomes for VV-ECMO and VA-ECMO together with @ELSOOrg guidelines
Indications and ... with @ELSOOrg guidelines ... VAECMO #VVECMO #Indications